117 related articles for article (PubMed ID: 22842622)
1. Use of (alternative) coreceptors for HIV entry.
Pollakis G; Paxton WA
Curr Opin HIV AIDS; 2012 Sep; 7(5):440-9. PubMed ID: 22842622
[TBL] [Abstract][Full Text] [Related]
2. Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection.
Cashin K; Jakobsen MR; Sterjovski J; Roche M; Ellett A; Flynn JK; Borm K; Gouillou M; Churchill MJ; Gorry PR
Retrovirology; 2013 Sep; 10():98. PubMed ID: 24041034
[TBL] [Abstract][Full Text] [Related]
3. Correlation of coreceptor usage and disease progression.
Verhofstede C; Nijhuis M; Vandekerckhove L
Curr Opin HIV AIDS; 2012 Sep; 7(5):432-9. PubMed ID: 22871636
[TBL] [Abstract][Full Text] [Related]
4. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.
Edinger AL; Hoffman TL; Sharron M; Lee B; O'Dowd B; Doms RW
Virology; 1998 Sep; 249(2):367-78. PubMed ID: 9791028
[TBL] [Abstract][Full Text] [Related]
5. Putative cholesterol-binding sites in human immunodeficiency virus (HIV) coreceptors CXCR4 and CCR5.
Zhukovsky MA; Lee PH; Ott A; Helms V
Proteins; 2013 Apr; 81(4):555-67. PubMed ID: 23161741
[TBL] [Abstract][Full Text] [Related]
6. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
[TBL] [Abstract][Full Text] [Related]
7. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
Chen Z; Gettie A; Ho DD; Marx PA
Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
[TBL] [Abstract][Full Text] [Related]
8. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
9. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
10. Characterization of HIV-2 chimeric viruses unable to use CCR5 and CXCR4 coreceptors.
Santos-Costa Q; Mansinho K; Moniz-Pereira J; Azevedo-Pereira JM
Virus Res; 2009 Jun; 142(1-2):41-50. PubMed ID: 19200444
[TBL] [Abstract][Full Text] [Related]
11. HIV type 1 tropism and inhibitors of viral entry: clinical implications.
Weber J; Piontkivska H; Quiñones-Mateu ME
AIDS Rev; 2006; 8(2):60-77. PubMed ID: 16848274
[TBL] [Abstract][Full Text] [Related]
12. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.
Berger EA; Murphy PM; Farber JM
Annu Rev Immunol; 1999; 17():657-700. PubMed ID: 10358771
[TBL] [Abstract][Full Text] [Related]
13. Evidence of extended alternate coreceptor usage by HIV-1 clade C envelope obtained from an Indian patient.
Gharu L; Ringe R; Bhattacharya J
Virus Res; 2012 Jan; 163(1):410-4. PubMed ID: 22086059
[TBL] [Abstract][Full Text] [Related]
14. Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120(V3) signatures in the regulation of co-receptor usage.
Dimonte S; Babakir-Mina M; Mercurio F; Di Pinto D; Ceccherini-Silberstein F; Svicher V; Perno CF
Virus Res; 2012 Sep; 168(1-2):73-83. PubMed ID: 22732432
[TBL] [Abstract][Full Text] [Related]
15. CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1.
Joly M; Pinto JM
Math Biosci; 2005 May; 195(1):92-126. PubMed ID: 15893340
[TBL] [Abstract][Full Text] [Related]
16. Emergence, dominance, and possible decline of CXCR4 chemokine receptor usage during the course of HIV infection.
Meehan CJ; Hedge JA; Robertson DL; McCormack GP; Travers SA
J Med Virol; 2010 Dec; 82(12):2004-12. PubMed ID: 20981786
[TBL] [Abstract][Full Text] [Related]
17. CD4-Dependent and CD4-independent utilization of coreceptors by human immunodeficiency viruses type 2 and simian immunodeficiency viruses.
Liu HY; Soda Y; Shimizu N; Haraguchi Y; Jinno A; Takeuchi Y; Hoshino H
Virology; 2000 Dec; 278(1):276-88. PubMed ID: 11112502
[TBL] [Abstract][Full Text] [Related]
18. Roles of chemokines and chemokine receptors in HIV-1 infection.
Murakami T; Yamamoto N
Int J Hematol; 2000 Dec; 72(4):412-7. PubMed ID: 11197206
[TBL] [Abstract][Full Text] [Related]
19. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
[TBL] [Abstract][Full Text] [Related]
20. The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection.
Moore JP; Kitchen SG; Pugach P; Zack JA
AIDS Res Hum Retroviruses; 2004 Jan; 20(1):111-26. PubMed ID: 15000703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
